There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To study real-world ranibizumab therapy for treatment-naïve eyes with neovascular
age-related macular degeneration (nAMD) and to benchmark standards of care.